Browse
Submit Data
Databases
API
Help

Dataset Information

27 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Phosphorescent platinum(II) and palladium(II) complexes with azatetrabenzoporphyrins-new red laser diode-compatible indicators for optical oxygen sensing.

ABSTRACT: A new class of oxygen indicators is described. Platinum(II) and palladium(II) complexes of azatetrabenzoporphyrins occupy an intermediate position between tetrabenzoporphyrins and phthalocyanines and combine features of both. The new dyes are excitable in the red part of the spectrum and possess strong room-temperature NIR phosphorescence. Other features include excellent spectral compatibility with the red laser diodes and 632.8 nm line of He-Ne laser, excellent photostability, and significantly shorter decay times than for the respective meso-tetraphenyltetrabenzoporphyrins. Applicability of the complexes for optical oxygen sensing is demonstrated.

SUBMITTER: Borisov SM

PROVIDER: S-EPMC2828183 | biostudies-literature | 2010 Feb

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Phosphorescent platinum(II) and palladium(II) complexes with azatetrabenzoporphyrins-new red laser diode-compatible indicators for optical oxygen sensing.

Borisov Sergey M SM Zenkl Gunter G Klimant Ingo I

ACS applied materials & interfaces 20100201 2

A new class of oxygen indicators is described. Platinum(II) and palladium(II) complexes of azatetrabenzoporphyrins occupy an intermediate position between tetrabenzoporphyrins and phthalocyanines and combine features of both. The new dyes are excitable in the red part of the spectrum and possess strong room-temperature NIR phosphorescence. Other features include excellent spectral compatibility with the red laser diodes and 632.8 nm line of He-Ne laser, excellent photostability, and significantl ...[more]

PMID: 20186289

Similar Datasets

Red Photoactivatable Genetic Optical-Indicators.

Project description:Emerging genetically-encoded Ca2+-indicators (GECIs) are intensiometric reporters that increase in fluorescence when bound to Ca2+; highly suited for studying calcium-signaling in many cell types, notably neurons. Today, major efforts are devoted toward optimizing red-emitting [red fluorescent protein (RFP)-based] GECIs (R-GECI), as these provide several advantages over GFP-based reporters, for instance, increased imaging depth, reduced photodamage by longer imaging wavelengths and, in principle, are better suited for use with prevalent blue-absorbing optogenetic tools (e.g., channelrhodopsin). However, excessive fluorescence from intersecting neighboring cells in very dense tissues, notably the brain, hinders the ability to collect signals from single cells and their processes. This challenge can be addressed by photoactivatable (PA) fluorescent proteins that can be rendered fluorescent on demand by user-defined targeted light. This allows activation and, thereby, collection of fluorescent signals exclusively from desired cells and their processes, while leaving all neighboring cells in the dark (i.e., non-fluorescent). Nevertheless, there are no PA R-GECIs. Here, we sought to develop PA-R-GECIs. To do so, we initially explored a recently discovered phenomenon of Ca2+-independent increases in fluorescence (i.e., artifacts) in an emerging R-GECI, which has led us to rationally engineer several functional PA-R-GECIs. We also take advantage of our findings to quickly engineer a novel PA-RFP, namely, PA-mRuby3.

| S-EPMC7270359 | biostudies-literature

Highly phosphorescent platinum(ii) emitters: photophysics, materials and biological applications.

Project description:In recent years a blossoming interest in the synthesis, photophysics and application of phosphorescent Pt(ii) complexes, particularly on their uses in bioimaging, photocatalysis and phosphorescent organic light-emitting diodes (OLEDs), has been witnessed. The superior performance of phosphorescent Pt(ii) complexes in these applications is linked to their diverse spectroscopic and photophysical properties, which can be systematically modulated by appropriate choices of auxiliary ligands. Meanwhile, an important criterion for the practical application of phosphorescent metal complexes is their stability which is crucial for biological utilization and industrial OLED applications. Taking both the luminescence properties and stability into consideration, chelating ligands having rigid scaffolds and with strong ?-donor atoms are advantageous for the construction of highly robust phosphorescent Pt(ii) complexes. The square-planar coordination geometry endows Pt(ii) complexes with the intriguing spectroscopic and photophysical properties associated with their intermolecular interactions in both the ground and excited states. In this article, we discuss the design and synthesis of phosphorescent Pt(ii) complexes with elaboration on the effects of ligands on the structure and luminescence properties. Based on their photophysical and emission properties, we intend to shed light on the great promise of highly robust phosphorescent Pt(ii) emitters in an array of applications from molecular materials to biosensors.

| S-EPMC6090519 | biostudies-literature

Palladium(II) and platinum(II) bind strongly to an engineered blue copper protein.

Project description:Studies of palladium(II) and platinum(II) binding to well-characterized proteins contribute to understanding the influence of these metals in the environment and body. The well-characterized apoprotein of azurin has a soft-metal binding site that may be exposed to solvent by mutation of a coordinating His-117 residue to glycine (H117G). Palladium(II) and platinum(II) form strong 1:1 adducts with the apo form of H117G azurin. A combination of UV-vis, circular dichroism, and inductively coupled plasma mass spectrometry techniques suggests that the metal binds specifically at His-46 and Cys-112 of the protein.

| S-EPMC3217333 | biostudies-literature

Optical coherence tomography-guided laser microsurgery for blood coagulation with continuous-wave laser diode.

Project description:Blood coagulation is the clotting and subsequent dissolution of the clot following repair to the damaged tissue. However, inducing blood coagulation is difficult for some patients with homeostasis dysfunction or during surgery. In this study, we proposed a method to develop an integrated system that combines optical coherence tomography (OCT) and laser microsurgery for blood coagulation. Also, an algorithm for positioning of the treatment location from OCT images was developed. With OCT scanning, 2D/3D OCT images and angiography of tissue can be obtained simultaneously, enabling to noninvasively reconstruct the morphological and microvascular structures for real-time monitoring of changes in biological tissues during laser microsurgery. Instead of high-cost pulsed lasers, continuous-wave laser diodes (CW-LDs) with the central wavelengths of 450 nm and 532 nm are used for blood coagulation, corresponding to higher absorption coefficients of oxyhemoglobin and deoxyhemoglobin. Experimental results showed that the location of laser exposure can be accurately controlled with the proposed approach of imaging-based feedback positioning. Moreover, blood coagulation can be efficiently induced by CW-LDs and the coagulation process can be monitored in real-time with OCT. This technology enables to potentially provide accurate positioning for laser microsurgery and control the laser exposure to avoid extra damage by real-time OCT imaging.

| S-EPMC4645164 | biostudies-other

Improved Efficiency and Lifetime of Deep-Blue Hyperfluorescent Organic Light-Emitting Diode using Pt(II) Complex as Phosphorescent Sensitizer.

Project description:Although the organic light-emitting diode (OLED) has been successfully commercialized, the development of deep-blue OLEDs with high efficiency and long lifetime remains a challenge. Here, a novel hyperfluorescent OLED that incorporates the Pt(II) complex (PtON7-dtb) as a phosphorescent sensitizer and a hydrocarbon-based and multiple resonance-based fluorophore as an emitter (TBPDP and ν-DABNA) in the device emissive layer (EML), is proposed. Such an EML system can promote efficient energy transfer from the triplet excited states of the sensitizer to the singlet excited states of the fluorophore, thus significantly improving the efficiency and lifetime of the device. As a result, a deep-blue hyperfluorescent OLED using a multiple resonance-based fluorophore (ν-DABNA) with Commission Internationale de L'Eclairage chromaticity coordinate y below 0.1 is demonstrated, which attains a narrow full width at half maximum of ≈17 nm, fourfold increased maximum current efficiency of 48.9 cd A-1 , and 19-fold improved half-lifetime of 253.8 h at 1000 cd m-2 compared to a conventional phosphorescent OLED. The findings can lead to better understanding of the hyperfluorescent OLEDs with high performance.

| S-EPMC8373157 | biostudies-literature

A highly CMOS compatible hafnia-based ferroelectric diode.

Project description:Memory devices with high speed and high density are highly desired to address the 'memory wall' issue. Here we demonstrated a highly scalable, three-dimensional stackable ferroelectric diode, with its rectifying polarity modulated by the polarization reversal of Hf0.5Zr0.5O2 films. By visualizing the hafnium/zirconium lattice order and oxygen lattice order with atomic-resolution spherical aberration-corrected STEM, we revealed the correlation between the spontaneous polarization of Hf0.5Zr0.5O2 film and the displacement of oxygen atom, thus unambiguously identified the non-centrosymmetric Pca21 orthorhombic phase in Hf0.5Zr0.5O2 film. We further implemented this ferroelectric diode in an 8 layers 3D array. Operation speed as high as 20?ns and robust endurance of more than 109 were demonstrated. The built-in nonlinearity of more than 100 guarantees its self-selective property that eliminates the need for external selectors to suppress the leakage current in large array. This work opens up new opportunities for future memory hierarchy evolution.

| S-EPMC7070068 | biostudies-literature

Diarylboron-Based Asymmetric Red-Emitting Ir(III) Complex for Solution-Processed Phosphorescent Organic Light-Emitting Diode with External Quantum Efficiency above 28.

Project description:Organic light-emitting diodes (OLEDs) are one of the most promising technologies for future displays and lighting. Compared with the blue and green OLEDs that have achieved very high efficiencies by using phosphorescent Ir(III) complexes, the red OLEDs still show relatively low efficiencies because of the lack of high-performance red-emitting Ir(III) complexes. Here, three highly efficient asymmetric red-emitting Ir(III) complexes with two different cyclometalating ligands made by incorporating only one electron-deficient triarylboron group into the nitrogen heterocyclic ring are reported. These complexes show enhanced photoluminescence quantum yields up to 0.96 and improved electron transporting capacity. In addition, the asymmetric structure can help to improve the solubility of Ir(III) complexes, which is crucial for fabricating OLEDs using the solution method. The photoluminescent and oxidation-reduction properties of these Ir(III) complexes are investigated both experimentally and theoretically. Most importantly, a solution-processed red OLED achieves extremely high external quantum efficiency, current efficiency, and power efficiency with values of 28.5%, 54.4 cd A-1, and 50.1 lm W-1, respectively, with very low efficiency roll-off. Additionally, the related device has a significantly extended operating lifetime compared with the reference device. These results demonstrate that the asymmetric diarylboron-based Ir(III) complexes have great potential for fabricating high-performance red OLEDs.

| S-EPMC5979779 | biostudies-literature

An all-silicon passive optical diode.

Project description:A passive optical diode effect would be useful for on-chip optical information processing but has been difficult to achieve. Using a method based on optical nonlinearity, we demonstrate a forward-backward transmission ratio of up to 28 decibels within telecommunication wavelengths. Our device, which uses two silicon rings 5 micrometers in radius, is passive yet maintains optical nonreciprocity for a broad range of input power levels, and it performs equally well even if the backward input power is higher than the forward input. The silicon optical diode is ultracompact and is compatible with current complementary metal-oxide semiconductor processing.

| S-EPMC5563475 | biostudies-literature

Semiconductor diode laser device adjuvanting intradermal vaccine.

Project description:A brief exposure of skin to a low-power, non-tissue damaging laser light has been demonstrated to augment immune responses to intradermal vaccination. Both preclinical and clinical studies show that this approach is simple, effective, safe and well tolerated compared to standard chemical or biological adjuvants. Until now, these laser exposures have been performed using a diode-pumped solid-state laser (DPSSL) devices, which are expensive and require labor-intensive maintenance and special training. Development of an inexpensive, easy-to-use and small device would form an important step in translating this technology toward clinical application. Here we report that we have established a handheld, near-infrared (NIR) laser device using semiconductor diodes emitting either 1061, 1258, or 1301nm light that costs less than $4000, and that this device replicates the adjuvant effect of a DPSSL system in a mouse model of influenza vaccination. Our results also indicate that a broader range of NIR laser wavelengths possess the ability to enhance vaccine immune responses, allowing engineering options for the device design. This small, low-cost device establishes the feasibility of using a laser adjuvant approach for mass-vaccination programs in a clinical setting, opens the door for broader testing of this technology with a variety of vaccines and forms the foundation for development of devices ready for use in the clinic.

| S-EPMC5576344 | biostudies-literature

Highly luminescent palladium(ii) complexes with sub-millisecond blue to green phosphorescent excited states. Photocatalysis and highly efficient PSF-OLEDs.

Project description:Palladium(ii) complexes supported by tetradentate [N^C^C^N] and [O^N^C^N] ligand systems display sky blue to red phosphorescence with emission quantum yields and emission lifetimes up to 0.64 and 272 ?s, respectively. Femtosecond time-resolved fluorescence (fs-TRF) measurements on these Pd(ii) complexes reveal a fast intersystem crossing from singlet to triplet manifolds with time constants of 0.6-21 ps. DFT/TDDFT calculations revealed that, as a result of the spiro-fluorene and bridging tertiary amine units of the ligands, the T1 excited state is more ligand-localized and has smaller structural distortion, leading to slower non-radiative decay as well as radiative decay of T1 ? S0 transition and thereby highly emissive, long-lived triplet excited states. The Pd(ii) complexes have been found to be efficient catalysts for visible light-driven, reductive C-C bond formation from unactivated alkyl bromides with conversions and yields of up to 90% and 83%, respectively. These complexes have also been employed as photosensitizers for [2 + 2] cycloaddition of styrenes, with conversions and yields comparable to those of the reported Ir(iii) complexes. Both green and sky blue organic-light emitting devices (OLEDs) have been generated with these Pd(ii) complexes as guest emitters. Maximum external quantum efficiencies (EQE) of up to 16.5% have been achieved in the sky blue OLEDs. The long emission lifetimes render the Pd(ii) complexes good sensitizers for phosphor-sensitized fluorescent OLEDs (PSF-OLEDs). By utilizing these phosphorescent Pd(ii) complexes as sensitizers, highly efficient green and yellow PSF-OLEDs having high EQE (up to 14.3%), high colour purity and long operation lifetimes, with 90% of initial luminance (LT90) for more than 80?000 h, have been realized.

| S-EPMC6024183 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data